Related Experiment Video

Updated: May 8, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Mathematical modeling of tumor growth, drug-resistance, toxicity, and optimal therapy design

Marios M Hadjiandreou, Georgios D Mitsis

    IEEE Transactions on Bio-Medical Engineering
    |September 12, 2013
    PubMed

    Insights

    Mathematical modeling and optimal control can optimize cancer treatment. Strategic treatment interruptions are key to controlling drug-resistant colon cancer progression in mice.

    Area of Science:

    • Oncology
    • Mathematical Biology
    • Pharmacology

    Background:

    • Tumor progression and treatment response are complex.
    • Mathematical modeling offers a quantitative approach to understanding cancer dynamics.
    • Optimal control theory provides tools for designing effective therapeutic strategies.

    Purpose of the Study:

    • To develop a mathematical model integrating tumor growth, drug effects, and toxicity.
    • To design optimal therapeutic patterns for colon cancer in mice, including cases with drug resistance.
    • To investigate the role of treatment interruptions in managing resistant tumors.

    Main Methods:

    • Utilized a Gompertz-type growth law for tumor progression.
    • Employed a pharmacokinetic-pharmacodynamic (PK/PD) model for drug effects.
    • Integrated toxicity models to assess side effects.
    • Applied optimal control techniques to determine treatment strategies.

    Main Results:

    • Successfully modeled colon cancer progression in untreated and treated mice.
    • Developed models for drug pharmacokinetics and toxicity.
    • Demonstrated that optimal planning of treatment interruption frequency and magnitude is crucial for controlling drug-resistant cancer.
    • Identified a promising methodology for managing cancer progression in the presence of drug resistance.

    Conclusions:

    • Mathematical modeling and optimal control are powerful tools for cancer treatment planning.
    • Strategic interruption of anticancer therapies is essential for overcoming drug resistance.
    • Further experimental investigation is warranted to validate these findings in clinical settings.

    More Related Videos

    A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

    A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

    Published on: April 6, 2016

    Related Concept Videos

    Pharmacodynamic Models: Overview01:27

    Pharmacodynamic Models: Overview

    Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
    Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

    Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

    Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
    The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
    Pharmacokinetic Models: Comparison and Selection Criterion01:26

    Pharmacokinetic Models: Comparison and Selection Criterion

    Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
    Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
    Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

    Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

    The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
    On the other hand, integral calculus focuses on...
    Pharmacokinetic Models: Overview01:20

    Pharmacokinetic Models: Overview

    Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
    There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
    Analysis of Population Pharmacokinetic Data01:12

    Analysis of Population Pharmacokinetic Data

    Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...